US Stock MarketDetailed Quotes
ENVB Enveric Biosciences
- 0.5010
- +0.0009+0.18%
Close Sep 13 16:00 ET
- 0.5000
- -0.0010-0.20%
Post 19:59 ET
4.47MMarket Cap-143P/E (TTM)
0.5190High0.4965Low45.26KVolume0.5190Open0.5001Pre Close22.83KTurnover0.51%Turnover RatioLossP/E (Static)8.92MShares2.920052wk High0.83P/B4.43MFloat Cap0.410052wk Low--Dividend TTM8.85MShs Float67500.0000Historical High--Div YieldTTM4.50%Amplitude0.4100Historical Low0.5040Avg Price1Lot Size
Enveric Biosciences Key Stats
Quarterly+Annual
YOY
| (Q2)Jun 30, 2024 | (Q1)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q4)Dec 31, 2023 | (Q3)Sep 30, 2023 | (Q2)Jun 30, 2023 | (Q1)Mar 31, 2023 | (FY)Dec 31, 2022 | (Q4)Dec 31, 2022 | (Q3)Sep 30, 2022 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Total revenue | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Operating revenue | --0 | --0 | --0 | --0 | --0 | --0 | --0 | --0 | --0 | --0 |
| Cost of revenue | ||||||||||
| Gross profit | ||||||||||
| Operating expense | -67.02%1.9M | -49.03%2.48M | -8.34%18.3M | -11.86%4.23M | -39.04%3.45M | 22.27%5.76M | 1.35%4.86M | -26.26%19.96M | -63.42%4.8M | 60.85%5.66M |
| Selling and administrative expenses | -60.35%1.3M | -34.41%1.93M | -7.80%10.7M | -1.53%2.78M | -42.80%2.01M | 30.85%3.27M | 6.52%2.95M | -46.33%11.61M | -73.02%2.82M | 65.48%3.51M |
| -General and administrative expense | -60.35%1.3M | -34.41%1.93M | -7.80%10.7M | -1.53%2.78M | -42.80%2.01M | 30.85%3.27M | 6.52%2.95M | -46.33%11.61M | -73.02%2.82M | 65.48%3.51M |
| Research and development costs | -78.48%515.5K | -74.91%458.16K | -9.66%7.25M | -27.69%1.37M | -34.24%1.35M | 13.00%2.4M | -6.79%1.83M | 67.64%8.03M | -24.05%1.89M | 68.59%2.06M |
| Depreciation amortization depletion | -2.01%84.78K | -1.25%85.41K | 4.90%343.98K | -2.10%84.68K | -0.40%86.3K | 1.19%86.52K | 24.86%86.49K | -50.06%327.91K | -49.80%86.5K | -50.12%86.65K |
| -Depreciation and amortization | -2.01%84.78K | -1.25%85.41K | 4.90%343.98K | -2.10%84.68K | -0.40%86.3K | 1.19%86.52K | 24.86%86.49K | -50.06%327.91K | -49.80%86.5K | -50.12%86.65K |
| Operating profit | 67.02%-1.9M | 49.03%-2.48M | 8.34%-18.3M | 11.86%-4.23M | 39.04%-3.45M | -22.27%-5.76M | -1.35%-4.86M | 26.26%-19.96M | 63.42%-4.8M | -60.85%-5.66M |
| Net non-operating interest income expense | -103.82%-35 | 6,427.27%696 | 170.64%3.71K | 519.26%566 | 826.30%2.24K | 237.13%916 | 99.73%-11 | 49.12%-5.25K | 97.37%-135 | 16.76%-308 |
| Non-operating interest income | ---- | ---- | --3.71K | ---- | ---- | ---- | ---- | ---- | ---- | ---- |
| Non-operating interest expense | ---- | ---- | ---- | ---- | ---- | ---- | ---- | -49.12%5.25K | ---- | ---- |
| Total other finance cost | 103.82%35 | -6,427.27%-696 | ---- | ---- | -826.30%-2.24K | ---916 | --11 | ---- | ---- | --308 |
| Other net income (expense) | 103.09%18.57K | -88.30%21.44K | 10,976.86%1.03M | 115.26%818.41K | -80.16%630.54K | -131.40%-601.96K | -33.63%183.16K | 100.03%9.3K | 85.28%-5.36M | 294.89%3.18M |
| Gain on sale of security | 103.09%18.57K | -88.30%21.44K | -86.20%1.03M | -60.88%818.41K | -80.16%630.54K | -131.40%-601.96K | -33.63%183.16K | -19.99%7.46M | -7.03%2.09M | 294.89%3.18M |
| Special income (charges) | ---- | ---- | --0 | ---- | ---- | ---- | ---- | 80.73%-7.45M | ---- | ---- |
| -Less:Impairment of capital assets | ---- | ---- | --0 | ---- | ---- | ---- | ---- | -80.73%7.45M | ---- | ---- |
| Income before tax | 70.43%-1.88M | 47.51%-2.46M | 13.50%-17.26M | 66.41%-3.41M | -13.58%-2.82M | -127.77%-6.36M | -3.39%-4.68M | 64.63%-19.96M | 79.49%-10.16M | 8.61%-2.48M |
| Income tax | 0 | 1.73K | 101.95%28.91K | 101.50%22.32K | 6.6K | 0 | 0 | 80.07%-1.49M | -1.49M | 0 |
| Net income | 70.43%-1.88M | 47.47%-2.46M | 6.39%-17.29M | 60.41%-3.44M | -13.85%-2.82M | -127.77%-6.36M | -3.39%-4.68M | 62.29%-18.47M | 79.39%-8.68M | 8.61%-2.48M |
| Net income continuous Operations | 70.43%-1.88M | 47.47%-2.46M | 6.39%-17.29M | 60.41%-3.44M | -13.85%-2.82M | -127.77%-6.36M | -3.39%-4.68M | 62.29%-18.47M | 79.39%-8.68M | 8.61%-2.48M |
| Minority interest income | 0 | 0 | -42.32%19.04K | 0 | 0 | -14.04%6.71K | 12.33K | 33.01K | 12.6K | 12.6K |
| Net income attributable to the parent company | 70.46%-1.88M | 47.61%-2.46M | 6.45%-17.31M | 60.46%-3.44M | -13.27%-2.82M | -127.38%-6.36M | -3.67%-4.69M | 62.22%-18.5M | 79.36%-8.69M | 8.14%-2.49M |
| Preferred stock dividends | -50.00%147.99K | 0 | -50.00%37K | 110.99K | 295.98K | 110.99K | 110.99K | |||
| Other preferred stock dividends | ||||||||||
| Net income attributable to common stockholders | 70.63%-1.88M | 48.82%-2.46M | 7.14%-17.46M | 60.96%-3.44M | -8.44%-2.82M | -122.81%-6.4M | -6.12%-4.8M | 61.61%-18.8M | 79.10%-8.8M | 4.05%-2.6M |
| Basic earnings per share | 91.78%-0.25 | 73.59%-0.61 | 37.77%-8.09 | 69.94%-1.47 | 10.96%-1.3 | -11.36%-3.04 | 56.74%-2.31 | 87.46%-13 | 94.38%-4.89 | 75.30%-1.46 |
| Diluted earnings per share | 91.78%-0.25 | 73.59%-0.61 | 37.77%-8.09 | 69.94%-1.47 | 10.96%-1.3 | -11.36%-3.04 | 56.74%-2.31 | 87.46%-13 | 94.38%-4.89 | 75.30%-1.46 |
| Dividend per share | ||||||||||
| Currency Unit | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD |
| Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
| Audit Opinions | -- | -- | Unqualified Opinion with Explanatory Notes | -- | -- | -- | -- | Unqualified Opinion with Explanatory Notes | -- | -- |
Analysis
Price Target
No Data
Heat List
US
Overall
Symbol
Latest Price
% Chg
No Data